The medical writing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for medical writing and strategies:
In April 2024, Cactus Life Sciences, a leading scientific communications agency that works with blue chip pharma and biotechnology companies, acquired nspm and eluSCIdate, two dynamic medical communications companies headquartered in Switzerland. (Source: Company Press Release)
In October 2023, Certara, Inc., a global leader in biosimulation software and advanced drug development solutions, launched CoAuthor, a writing software suite designed to revolutionize the creation and review of critical clinical trial documents in the pharmaceutical industry. (Source: Company Press Release)
source:https://www.theinsightpartners.com
https://www.theinsightpartners.com/assets/images/other/report-deliverables-img1.webp
